Skip to content
Search

Latest Stories

Early menopause increases health risks after 60: study

Women who undergo premature menopause are almost three times more likely to develop multiple, chronic medical problems in their sixties than women who make the transition at 50 or 51, researchers reported Monday.

In high-income countries, a third of a woman’s life unfolds after the menopause.


Earlier research showed that premature menopause at 40 or younger is linked later in life to single medical problems such as cardiovascular disease and diabetes.

But the new study, published in Human Reproduction, is the first to examine links between the timing of natural menopause and the onset of multiple medical conditions, known as multimorbidity, the authors said.

The data were drawn from more than 5,100 women enrolled in an Australian national health survey.

The women reported at three-year intervals from 1996 to 2016 on whether they had been diagnosed with any of 11 health problems, including diabetes, high blood pressure, heart disease, stroke, arthritis, osteoporosis, asthma, depression, anxiety or breast cancer.

Multimorbidity was defined as having two or more of these conditions at the same time.

The women were considered to have entered natural menopause after 12 months without monthly periods.

During the 20-year follow-up, more than half of the 2.3 percent of women who experienced premature menopause also developed multimorbidity.

Compared with women who experienced menopause at the age of 50-51 years, they were twice as likely to develop multimorbidity by the age of 60, and three times more likely to experience it after 60.

"Forty-five percent of women with premature menopause had developed multimorbidity in their 60s compared with 40 percent of women who experienced menopause at the age of 50-51," said co-author Xiaolin Xu, a research professor at China's Zhejiang University.

The study does not show that premature menopause causes the development of multimorbidity, only that there is a strong correlation, the authors noted.

"Our findings indicate that multimorbidity is common in mid-aged and early-elderly women," said senior author Gita Mishra, director of the Centre for Longitudinal and Life Course Research at the University of Queensland, Brisbane.

"Premature menopause is associated with an increased risk of developing multimorbidity, even after adjusting for previous chronic conditions."

Number of children, level of education, body mass index, tobacco consumption, and physical activity were also taken into account.

Health professionals should consider providing comprehensive screening and assessment of risk factors when treating women who experience natural premature menopause, the authors recommended.

(AFP)

More For You

RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less